Industry in Spain welcomes new health minister as drug spending falls and hospital debt grows
This article was originally published in Scrip
Spain's new conservative government, led by the Partido Popular (People's Party), has named Ana Mato as its new health minister. She comes to office as spending on drugs continues to plummet and the authorities owe pharmaceutical companies some €5.8 billion. Both Farmaindustria and AESEG, which represent R&D-based companies and generics firms respectively, will be seeking a meeting with the minister.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.